Hypertension and renal dysfunction: NHANES III
- PMID: 12819306
- DOI: 10.1097/01.asn.0000070146.29445.d8
Hypertension and renal dysfunction: NHANES III
Abstract
The incidence rate of end-stage renal disease has increased in many countries in the past 20 yr, including the United States and Singapore. The increase in ESRD incidence in the United States is primarily attributable to diabetes and to hypertension. In Singapore the major cause of ESRD is diabetes, however the prevalence of hypertension in the Singapore population is rising rapidly, and renal complications of hypertension may become more common in the future. Information on the association of hypertension with renal dysfunction and ESRD in the United States may be useful in predicting future trends in the incidence of ESRD due to hypertension in Singapore. This paper describes published and unpublished data presented at a conference to assist in developing plans for a comprehensive renal disease prevention program in Singapore. It compares recent data on the reported prevalence of hypertension in the United States and Singapore; and presents information on the association of hypertension with serum creatinine, urinary albumin excretion, and ESRD in the United States.
Similar articles
-
Hypertension awareness, treatment, and control in chronic kidney disease.Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025. Am J Med. 2008. PMID: 18374693
-
Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S76-80. doi: 10.1097/01.asn.0000070145.00225.ec. J Am Soc Nephrol. 2003. PMID: 12819307 Review.
-
Hypertension in pediatric long-term hemodialysis patients in the United States.Clin J Am Soc Nephrol. 2009 Aug;4(8):1363-9. doi: 10.2215/CJN.01440209. Epub 2009 Jun 25. Clin J Am Soc Nephrol. 2009. PMID: 19556378 Free PMC article.
-
Projecting the number of patients with end-stage renal disease in the United States to the year 2015.J Am Soc Nephrol. 2005 Dec;16(12):3736-41. doi: 10.1681/ASN.2005010112. Epub 2005 Nov 2. J Am Soc Nephrol. 2005. PMID: 16267160
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
Cited by
-
Adult chronic kidney disease: neurocognition in chronic renal failure.Neuropsychol Rev. 2010 Mar;20(1):33-51. doi: 10.1007/s11065-009-9110-5. Epub 2009 Aug 25. Neuropsychol Rev. 2010. PMID: 19705282 Review.
-
Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.Am J Physiol Regul Integr Comp Physiol. 2012 Jul 1;303(1):R57-69. doi: 10.1152/ajpregu.00263.2011. Epub 2012 Apr 25. Am J Physiol Regul Integr Comp Physiol. 2012. PMID: 22538513 Free PMC article.
-
Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease.Prostaglandins Other Lipid Mediat. 2014 Oct;113-115:45-51. doi: 10.1016/j.prostaglandins.2014.08.002. Epub 2014 Aug 22. Prostaglandins Other Lipid Mediat. 2014. PMID: 25151892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous